Plain-English translation of NCT06865105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two medications called and to see if they work better alone or together for treating psoriatic arthritis—a condition where your immune system attacks your joints and skin. About 120 people will be randomly assigned to receive one of three treatment options: alone, alone, or both medications together. The study will measure how well these treatments reduce joint pain, swelling, and stiffness.
Many people with psoriatic arthritis don't respond well enough to existing treatments, or they stop working over time. This study is looking for new options—including combination therapy—that might help people whose current medications aren't controlling their symptoms effectively.
You likely qualify if…
You likely don't qualify if…
You will visit a hospital or clinic regularly throughout the study to receive your assigned medication and have your health checked. At each visit, the study team will examine your joints, run blood tests, check for side effects, and ask you questions about your symptoms. You will be randomly assigned to one of three groups: receive injections, injections (starting with one dose and then a higher dose every two weeks), or both medications together on the same schedule. The study involves more frequent visits and procedures than your regular medical care, so expect a higher time commitment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States